Tanya Doctorian, Daniel Serna, Blanding Jones, Arti Choure1, Ramdas Pai4, Eric Chou1 and William Mosley II1
With Transcatheter Aortic Valve Replacement (TAVR) revolutionizing the treatment of high-surgical risk patients with severe aortic stenosis, Transcatheter Mitral Valve Replacement (TMVR) is slowly emerging as an off-label therapy for severe mitral valve disease. A case of 70-year-old female with recurrent history of congestive heart failure has been described. This case demonstrates the simultaneous TAVR and off-label VIV TMVR is a reasonable alternative for highrisk surgical patients with stenotic native and failing bioprosthetic valves.
details summary { cursor: pointer; color: #f8f9fa; } a { font-size: 11px; opacity: 0.5; }References Yacht Charter in Saudi Arabia Blog | Education Technologies Articles Yacht Charter in Turkey Blog | Cooling Technologies Articles Yacht Charter in UK Blog - Find Lawyer in New York Yacht Charter in USA Blog | Web Technologies Articles Places to Visit in Australia Blog | Best Betting Sites in Venezuela Places to Visit in Belgium Blog | Casino Sites in New Zealand Places to Visit in Brazil Blog | Cardiology Articles Places to Visit in Canada Blog - Find Lawyer in Massachusetts Blog - Find Lawyer in Wisconsin Places to Visit in Czech Republic Blog - Find Lawyer in North Carolina Places to Visit in Germany
